Susquehanna International Group
SANA icon

Susquehanna International Group’s Sana Biotechnology SANA Stock Holding History

Susquehanna International Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
73,900
-45,300
-38% -$178K ﹤0.01% 11564
2025
Q4 		$485K Sell
119,200
-12,300
-9% -$55.1K ﹤0.01% 8858
2025
Q3 		$467K Buy
131,500
+1,100
+0.8% +$3.98K ﹤0.01% 9122
2025
Q2 		$356K Sell
130,400
-6,700
-5% -$13.8K ﹤0.01% 9959
2025
Q1 		$230K Buy
137,100
+71,500
+109% +$200K ﹤0.01% 10638
2024
Q4 		$107K Sell
65,600
-46,400
-41% -$138K ﹤0.01% 11293
2024
Q3 		$466K Buy
112,000
+22,600
+25% +$119K ﹤0.01% 8626
2024
Q2 		$488K Sell
89,400
-3,300
-4% -$26.3K ﹤0.01% 8326
2024
Q1 		$927K Buy
+92,700
New +$694K ﹤0.01% 7095
2022
Q3 		– Sell
-16,200
Closed -$104K – 13998
2022
Q2 		$104K Buy
16,200
+1,200
+8% +$7.64K ﹤0.01% 11444
2022
Q1 		$124K Buy
15,000
+2,500
+20% +$20.2K ﹤0.01% 11749
2021
Q4 		$194K Buy
+12,500
New +$241K ﹤0.01% 11482

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Susquehanna International Group's SANA Position: Q1 2026 in Review

Susquehanna International Group reduced its Sana Biotechnology (SANA) stake by 25% in Q1 2026, selling an estimated $544K and leaving 421,555 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Susquehanna International Group first reported a position in SANA in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.28M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Susquehanna International Group held 421,555 shares of Sana Biotechnology worth $1.21M as of Q1 2026.
  • Susquehanna International Group sold 138,195 Sana Biotechnology shares in Q1 2026, an estimated $544K.
  • Sana Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7391 holding.
  • Susquehanna International Group first reported a position in Sana Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Sana Biotechnology position peaked at $2.28M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.